ReviewIndian journal of surgical oncology2025
Risk Factors for Tumor Recurrence in Meningiomas: Multicenter Multivariate Analysis.
Review in Indian journal of surgical oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Fluorescence-guided surgery combined with intraoperative photodynamic therapy for recurrent atypical and anaplastic intracranial meningiomas: a prospective feasibility study.Frontiers in oncology · 2026Article
- Evolving treatment strategies in meningioma: from traditional approaches to emerging therapies.Annals of medicine and surgery (2012) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Meningiomas are among the most frequent primary brain tumors, so knowing the association of different factors with the imaging recurrence of meningiomas is important for post-surgical decision-making. We conducted a retrospective analysis in six high specialty hospitals in Mexico with 190 patients diagnosed with meningiomas and who underwent resection surgery from 2009 to 2019. A univariate and multivariate analysis was performed to identify different risk factors, a simple linear regression analysis for quantitative variables, and a comparison of means to identify the impact of the different factors with the months of survival free of tumor recurrence. A total of 190 patients were analyzed, with an overall recurrence rate of 38.9% (74 patients). Regarding risk factors, the onset of intracranial hypertension syndrome was associated with a higher risk of tumor recurrence at follow-up. The simple linear regression analysis found that the greater the intraoperative bleeding, the lower the survival rate of tumor recurrence. In the comparison analysis of means, the intracranial hypertension syndrome and the petroclival location significantly reduced the months of free survival of the tumor recurrence. We report that a clinical presentation such as intracranial hypertension syndrome increases the risk of recurrence in meningiomas up to eight times more and that the greater the intraoperative bleeding, the lower the survival free of recurrence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.